Advances in immunotherapy: Q&A with Prof Georgina Long AO | 27 min 1
In this interview from Keystone Symposia, MIA’s Prof Long talks to Dr Xin (Cindy) Sun about the latest advances in immunotherapy to treat melanoma. Prof Long provides insight into the greatest challenges in tackling melanoma, both molecularly and clinically, and new strategies to defeat the disease. They also discuss if cancer patients on immunotherapy are at a higher risk of developing Covid-19 and how clinicians are adapting cancer care during the pandemic.
This interview was part of Keystone Symposia’s eSymposia Virtual Meeting: Advances in Cancer Immunotherapy.
Professor Georgina Long AO
Co-Medical Director, Melanoma Institute Australia
Chair, Melanoma Medical Oncology and Translational Research,
Melanoma Institute Australia and Royal North Shore Hospital,
The University of Sydney
Declaration of Interest
Dr Xin (Cindy) Sun
Scientific Editor, Journal of Experimental Medicine, The Rockefeller University